Disruptive Innovations US Speakers
Rick Sax, MD
SVP, Clinical Design & Reporting Services
Rick is a 20-year veteran of the pharmaceutical industry, having held senior positions in Clinical Development at Merck & Co. and AstraZeneca. His career has included leading cardiovascular drug development at Merck, and leadership roles in the U.S. Business, Global Medical Sciences, and New Opportunities (AstraZeneca). Prior to joining Quintiles two years ago, he helped lead an effort at AstraZeneca to transform Clinical Development, focusing on improving program and protocol design. In his current role at Quintiles, he oversees the Biostatistics/Medical Writing/Regulatory group, Safety Knowledge & Reporting, and the Center for Integrated Drug Development – Quintile’s home for pharmaceutical drug development design and its enabling platform technology, Infosario Design.